Paclibar, Emilio S.

HRN: 21-82-59  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/22/2022
CEFUROXIME 750MG (VIAL)
08/22/2022
08/29/2022
IV
500
Q8
ATP
Waiting Final Action 
08/22/2022
CO-AMOXICLAV 457MG/5ML, 70ML SUSPENSION (BOT)
08/22/2022
08/29/2022
ORAL
1.25ml
TID
ATP
Waiting Final Action 
08/24/2022
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
08/24/2022
09/03/2022
PO
4.5 ML
Q8H
Amoebiasis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: